Litcius/Paper detail

Extended characterization of anti-CD19 CAR T cell products manufactured at the point of care using the CliniMACS Prodigy system: comparison of donor sources and process duration

Ekaterina A. Malakhova, Dmitry Pershin, Elena Kulakovskaya, Victoria A. Vedmedskaia, Maria Fadeeva, Oyuna Lodoeva, Tatiana Sozonova, Yakov Muzalevskii, Alexei Kazachenok, Vladislav Belchikov, Larisa Shelikhova, Olga Molostova, Dmitry V. Volkov, Michael Maschan

2024Cytotherapy10 citationsDOI

Topics & Concepts

CD19Characterization (materials science)Process (computing)Duration (music)Point (geometry)MedicineComputer scienceMathematicsMaterials scienceImmunologyPhysicsNanotechnologyAntigenOperating systemGeometryAcousticsCAR-T cell therapy researchImmunotherapy and Immune ResponsesViral Infectious Diseases and Gene Expression in Insects
Extended characterization of anti-CD19 CAR T cell products manufactured at the point of care using the CliniMACS Prodigy system: comparison of donor sources and process duration | Litcius